Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

NCT01196819 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Firehawk
DEVICE: Xience V

Sponsor

Shanghai MicroPort Medical (Group) Co., Ltd.